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Abstract 
Due to an increased incidence of human infections, livestock-associated methicillin-resistant 
Staphylococcus Aureus (LA-MRSA) in pigs and its spread into the human population has been a 
major public and political issue in Denmark. Similar concerns are also being raised about LA-
MRSA in other Western European countries. At a time when the proportion of LA-MRSA-
positive pig farms was low, Norway adopted a ‘trace and destroy’ strategy aimed at keeping 
LA-MRSA out of the pig population. However, to date, no country with a high proportion of 
LA-MRSA-positive pig herds has chosen to use an eradication strategy. This study analyses 
the cost and complexities of conducting an LA-MRSA eradication program in a situation 
where a large proportion of herds are positive. The total cost of the eradication program was 
estimated based on the following components: 1) planning, 2) monitoring and testing, 3) 
cleaning and disinfection, 4) production gains and losses, 5) net reduction in breeding exports, 
and 6) loss of genetic progress, including the costs of a mitigating caesarean section strategy in 
breeding herds. Costs were related to the depopulation of 1 million sows, to gilt supply (as this 
was an important limiting factor during an eradication program in Denmark), and to 
aggregated losses linked to a temporary halt on breeding progress. Using conservative 
assumptions, the total eradication costs were estimated at €1.8 billion, broken down into: 
                                                        
1 The reference of the printed version is: 
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associated methicillin-resistant staphylococcus aureus in countries with a high proportion of positive herds. 
Preventive Veterinary Medicine 158: 97-105. 
The definitive version is available at 
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planning costs (3%), monitoring and testing (6%), cleaning and disinfection (19%), production 
gains and losses (33%), net loss from breeding exports (19%) and loss of genetic progress 
(20%). The long-term effects of an LA-MRSA eradication program for Danish pig production 
were uncertain and were therefore not taken into account in the analysis.  
 
Keywords: LA-MRSA, CC398, Eradication, Cost Analysis 
 
 
Introduction 
The livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) clonal complex 
(CC) 398 has been reported in pig populations and humans in contact with pigs, especially 
farm workers (Voss et al., 2005; Armand-Lefevre et al., 2005), since 2004. The occurrence of 
LA-MRSA in Danish pig herds increased rapidly from 3% positive farms in 2008 to 88% 
positive farms in 2016 (Danish Veterinary and Food Administration, 2017). The pig 
population in Denmark therefore constitutes a major reservoir of LA-MRSA CC-398. In 
addition, there was an annual increase in the incidence of LA-MRSA CC398 infections within 
the Danish human population of 66% per year between 2004 and 2011 (Larsen et al., 2015). 
This, together with a fierce public debate among experts and stakeholders, amplified by media 
exposure, has prompted Danish politicians to consider control measures for LA-MRSA in 
Danish pig herds, as well as initiatives to prevent further spread to humans. 
 
In Norway, a country with an initially very low proportion of positive farms, a “trace and 
destroy” strategy has been implemented, through which farms delivering or receiving pigs from 
positive farms are tested. LA-MRSA-positive farms are depopulated without bringing pigs to 
slaughter, followed by re-stocking with uninfected animals after cleaning and disinfection of 
the premises. This strategy has a reported 90% probability of successfully eradicating LA-
MRSA on a positive Norwegian farm (Grøntvedt et al., 2016). It has been suggested by several 
influential stakeholders that the best option to control LA-MRSA in Danish pig herds would 
be to follow the Norwegian example and depopulate LA-MRSA-positive pig herds. Indeed, 
part of the political mandate of an expert group reconvened by the Danish Minister for the 
Environment, Food and Agriculture in 2016 was to consider this option. However, when the 
proportion of positive herds is as high as in Denmark, bottleneck issues and production 
constraints (e.g. the availability of replacement animals) adds to the complexity of the problem.   
When considering the costs and benefits of eradicating LA-MRSA from the Danish pig herd, it 
is important to realise that direct benefits are almost exclusively achieved outside the pig sector, 
i.e. in the public health sector. While it is important to consider these benefits when deciding 
whether or not to initiate an eradication program within a country, they are not relevant when 
trying to calculate the associated costs. Furthermore, societal costs associated with losses in 
slaughterhouses, feed mills and various other services for the primary pig industry are most 
likely to be directly related to a reduction in the number of pigs produced during eradication, 
and will depend on the structure of the pig industry in the country. Hence, societal costs are 
not considered further in this study. The costs incurred in the primary production sector, 
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however, can probably be extrapolated from the Danish situation to any industrialised pig 
production sector with a high proportion of LA-MRSA-positive farms.  
 
There may also be some indirect benefits of an LA-MRSA eradication program. For example, it 
may be possible to include the benefits of eradicating one or more further diseases such as 
Porcine Reproductive and Respiratory Syndrome (PRRS), Actinobacillus pleuropneumoniae 
and Enzootic Pneumonia into the cost analysis.  
 
The purpose of this study was to analyse the cost and complexities of conducting an 
eradication program for LA-MRSA-positive herds in Denmark – a country with a high 
proportion of positive herds to assess the production losses using similar methods as in 
previous studies (Houe, 2003; Rushton, 2009; Asheim et al., 2017; Thomann et al., 2017). The 
main challenge for our analysis is the uncertainty about the underlying assumptions, for 
example regarding reintroduction rate. To address this uncertainty, we use a conservative 
approach by which assumptions are chosen so that the combined costs reflect an optimistic 
estimate of the total cost, and by subsequently performing a sensitivity analysis comparing this 
estimate to the worst-case scenarios.  
 
 
Materials and methods 
Analytical approach 
The proposed eradication strategy consisted of: an initial one-year planning phase, a five-year 
eradication phase and a nine-year monitoring and control phase, during which LA-MRSA-
positive farms were depopulated and restocked. In total, a timescale of 15 years was 
considered. 
 
The cost of an LA-MRSA eradication program for the primary pig sector in Denmark was 
calculated as the net present value (NPV) of the costs and losses of the program (Eq. (1)). The 
cost analysis was divided into costs during the planning period, direct net costs during the 
eradication period, and derived net costs after the eradication period. The calculation was 
similar to that of Asheim (2017): 
 𝑁𝑃𝑉 =% 	−𝐶𝑜𝑠𝑡𝑃𝑟𝑜𝑔. − 𝐿𝑜𝑠𝑠𝑃𝑟𝑜𝑔.(1 + 𝑟).4.56  (1) 
 
Where 𝑖 is the year (with 2018 considered as the start of the eradication program); 𝑛 is the 
timescale of the program (15 years); 𝑟 is the real interest rate (4%). The CostProgi is the cost of 
the planning, testing and monitoring, cleaning, disinfection and caesarean section in year i 
(Fig. 1). LossProgi includes production losses, the losses from a reduced export of genetics, and 
losses from reduced breeding progress in year i. The expected benefits related to an 
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improvement in the health status of the pigs were subtracted from the losses. A static approach 
was adopted without assuming long-term effects on the farm or production structure.  
 
 
FIGURE 1. MODEL STRUCTURE FOR THE BREAKDOWN OF COSTS. DIRECT NET COSTS COVER 
PLANNING AND ERADICATION PHASES AND DERIVED NET COSTS COVER THE MONITORING 
PHASE FOLLOWING THE ERADICATION OF LA-MRSA IN DENMARK. 
 
The sensitivity was calculated using a static ceteris paribus analysis based on an assessment of 
relevant assumptions. The costs and losses were recalculated with one of the assumptions 
changed, and the difference compared to the baseline was calculated. If several assumptions 
were mutually dependent, the cumulative effect was calculated by changing these assumptions 
simultaneously and subtracting the baseline costs.  
 
Planning and initial screening 
It was assumed that 200 hours of planning were required per LA-MRSA-positive farm 
throughout the eradication and restocking phases based on previous Danish experience from 
the unsuccessful eradication attempts concerning Salmonella Typhimurium DT 104. The initial 
planning phase was set to one year, including an initial screening of all herds in Denmark to 
establish the LA-MRSA status of the farms. The planning phase would involve public 
authorities, veterinarians, consultants and farmers.  
Net costs
Derived net costs post 
eradication
Direct net eradication 
costs
Production loss
Net loss breeding 
export
Cleaning and 
disinfection
Monitoring and 
Testing
Planning
Cost of caesarean 
section
Costs Losses
Loss of genetic 
progress
Production loss, 
herds with 
reintroductions
Cleaning etc., 
herds with 
reintroductions
Net loss breeding 
export
Monitoring and 
Testing
Planning
Costs Losses
Loss of genetic 
progress
Gains from 
improved health
Planning costs
Planning
Costs
This is a post-print version of an article published in 
 Preventive Veterinary Medicine by Elsevier 
 
 5 
Testing and monitoring 
We assumed that all herds were tested during the planning phase (year one) to establish the 
true LA-MRSA status of all farms. During years two and three, one-third of the farms would 
each be tested four times per year. During years three and four, two-thirds of the farms would 
each be tested four times per year, and in the fifth year, all farms would be tested once to 
ensure that the eradication program had been successful. During years six to 15, all herds 
would be tested annually to confirm their continued negative status. Simulation studies have 
been conducted showing that frequent testing is necessary to keep the transmission rate 
between herds low. Each herd was tested with 5 pooled tests per herd at an expected cost of 
€934 per herd. 
 
Production gains and losses 
Production loss was calculated according to the following equation (Eq. (2)):  
 𝑃𝑟𝑜𝑑𝑢𝑐𝑡𝑖𝑜𝑛	𝑙𝑜𝑠𝑠 =%%	𝑝𝑟𝑜𝑑𝑢𝑐𝑡𝑖𝑜𝑛>? 	 ∙ 𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛	𝑜𝑓	𝑦𝑒𝑎𝑟>? ∙ 	𝑎𝑛𝑛𝑢𝑎𝑙	𝑔𝑟𝑜𝑠𝑠	𝑚𝑎𝑟𝑔𝑖𝑛?F?56G>56  (2) 
 
Where production was the total number of pigs from farms with LA-MRSA; fraction of year was 
the period with no pigs delivered from the farm; annual gross margin was the national average 
(see Appendix 1 for detailed description); j was the type of production (integrated = 1, 
specialised farms = 2), and k was the age group of the pigs (piglets = 1, weaners = 2, finishers = 
3).    
 
In farm accounts, not all variable costs are deducted from the revenue to obtain the gross 
margin (Huirne & Dijkhuizen, 1997). Nonetheless, gross margins are often used to 
approximate the losses during ceased production (Thomann et al., 2017). However, energy and 
labour costs are usually also affected by the eradication program because the number of pigs is 
lower during the eradication and restocking phase. The expected losses from the eradication 
program were therefore calculated as the gross margin adjusted with 50% of the energy and 
10% of labour costs during the depopulation and restocking period. Labour costs were not 
expected to decrease further due to additional cleaning tasks and logistic constraints on the 
workforce to avoid reintroduction of LA-MRSA through human contact.  
 
The eradication program evaluated in this study allowed for slaughter pigs to be reared to 
commercial weight and for piglets to be sold at a commercial price. However, a loss was 
expected due to productive sows being slaughtered prematurely. This loss was calculated using 
the costs associated with rearing gilts to about 35 weeks and buying 10% extra gilts, since they 
would not all be expected to be useful for production. 
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Cleaning and disinfection 
Cleaning and disinfection in relation to LA-MRSA was expected to be costly since the bacteria 
can survive in the environment. The scope of eradication was considered to be comparable to a 
Salmonella typhimurium DT104 eradication program, conducted (unsuccessfully) in Denmark in 
the late 1990s. The unpublished costs from this eradication program were divided into: 
destruction of feedstuffs (22%), cleaning and disinfection of pens (40%), cleaning of machinery 
and outdoor premises (14%) and reduction in slurry value (24%; Danish Pig Research Centre, 
unpublished). 
 
Loss of genetic progress 
Breeding is basically taking advantage of the variation in the genes within a species to choose 
the best performing individuals (Rauw, 2008). The traits selected in pig breeding maximise the 
economic return from pig farming (Pig Research Centre, 2014). An eradication program 
involving culling of breeding stock reduces the number of available pigs and – as a 
consequence – variation in the genes. This implies a reduction in the genetic progress for 
nucleus herds during the eradication program. After the eradication program, genetic progress 
would return to its previous growth rate. However, a perpetual disparity would remain 
between the breeding value with and the value without (baseline) an eradication program. 
 
The genetic progress in Danavl (cooperatively owned Danish breeding company) was 
estimated at €1.70 per pig per year (from birth to slaughter) as an average over four years and 
based on the progress of nine parameters (Pig Research Centre, 2014, 2016). These parameters 
were: growth rate, feed conversion ratio, leanness, living piglets at day five, conformation, 
killing out percentage, piglet growth, longevity, and paternal fertility (Pig Research Centre, 
2016). This average of €1.70 per pig reared from birth to slaughter was used to estimate the loss 
of breeding progress. About half of this genetic progress value was expected to be lost due to 
the depopulation of 86% of breeding pigs in the nucleus herds. This loss of genetic 
development was estimated assuming unchanged breeding value estimates for precision, 
variation in genetic material, and generational interval. For simplicity, these parameters are 
assumed to be independent of the eradication program. The equation used for genetic progress 
per year (Eq. (3)) was as follows (Jespersen 2008): 
 ∆𝐺JKLM = 𝑖	𝒓OP𝜎O𝐿  (3) 
 
Where (𝑖) is the selection intensity, (𝑟OP) is the precision of the breeding value estimates (i.e. the 
number of tests), (𝜎) is the variation in genetic material, and (𝐿) is the generational interval. 
The genetic progress for offspring is the average of the maternal and paternal contributions 
which are both calculated according to eq. 3. The probability of a positive LA-MRSA breeding 
herd was assumed to be independent of the breed and the herd size. Simplified assumptions of 
unchanged breeding value estimates for precision, variation in genetic material and 
generational interval were also made, so that the breeding progress was only dependent on the 
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selection intensity before and during the eradication program. The ex post selection intensity 
was based on there being 280 LA-MRSA-negative sows in each of the three breeds used in 
Danish pig breeding, each producing annually 2,800 useful gilts. See Appendix 2 for a 
calculation of the economic loss incurred due to loss of breeding progress.  
 
Caesarean sections 
It was assumed that the breeding progress loss could, in principle, be mitigated by caesarean 
sections in combination with artificial fostering of piglets, thus allowing LA-MRSA-negative 
piglets to be raised from positive sows. An eradication program using caesarean sections would 
be logistically challenging and involve high operating costs including those associated with 
transportation, caesarean clinics, veterinarians, and high gilt mortality. The number of 
caesareans was assumed to be sufficient to produce the necessary 4,600 high quality nucleus 
gilts the first year and an equal number of boars. See Appendix 2 for an approximation of costs 
related to caesarean sections used to maintain breeding progress. 
 
Loss of export value for gilts, boars and semen 
The eradication program was expected to reduce the export of gilts, boars and semen from 
breeding herds, resulting in a loss of revenue during the program. The effect on Danish 
companies of the delay in genetic progress during the eradication program (compared to 
companies doing their breeding outside Denmark) might mean that a full recovery of pre-
program markets is doubtful. However, due to our conservative approach in estimating costs, 
we assumed that we would regain full market access. A calculation of the loss of export value 
is presented in Appendix 3. 
 
Demographics of Danish pig production 
In 2016, 227 Danish pig herds were tested for LA-MRSA, resulting in an estimated proportion 
of 88% LA-MRSA-positive slaughter pig herds in Denmark (Danish Veterinary and Food 
Administration, 2017). Assuming a similar relationship exists to that found during a study 
conducted in 2014 (DANMAP, 2015) of 63% positive breeding herds and 68% positive 
slaughter pig herds, we assumed that the proportion of LA-MRSA-positive breeding herds was 
86%.  
 
In 2017, Danish pig production consisted of a yearly production of approximately 18 million 
slaughter pigs and 13 million weaner pigs for live export, from about 1 million sows. Table 1 
shows the estimated number of LA-MRSA-positive herds, categorised by type (Ministry of 
Environment and Food of Denmark, 2017). This was based on the assumption of 88% positive 
herds, and the distribution across different herd types is shown. 
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TABLE 1. ESTIMATED NUMBER OF LA-MRSA-POSITIVE DANISH PIG HERDS AND 
DISTRIBUTION OF PIGS (%) BY HERD TYPE, FROM THE HERD STATISTICS IN DENMARK 
Herd type Estimated number 
of LA-MRSA-
positive herds 
Sows  
(%) 
 Weaners 
(%) 
Finishers 
(%) 
Specialised sow herds 500 12 - - 
Specialised weaner herds 531 - 19 - 
Specialised finisher herds 3,642 - - 67 
Sows, weaners and finishers 1,286 61 39 12 
Sows and weaners 363 15 8 - 
Sows and finishers 256 11 - 1 
Weaners and finishers 896 - 34 20 
Total number of herds 7,474 100 100 100 
 
 
The Danish herd registry (CHR) defines a herd as a group of animals of the same species 
located together. According to this definition, a famer who owns two neighbouring farms 
would have two herds. We assumed that LA-MRSA could be eradicated from the herds 
independently.  
 
Assumptions 
We assumed an annual recurrence of LA-MRSA in 10% of the herds during the eradication 
phase. In the post-eradication monitoring period, reintroduction of LA-MRSA was assumed in 
5% of the herds per year. This was a conservative estimate based on Norwegian experience, 
where the prevalence initially was lower than in Denmark. This recurrence incurred costs for 
testing, monitoring, depopulation and restocking.  
 
The costs were converted from Danish kroner (DKK) to Euro using the conversion rate of 
7.44 DKK/Euro of June 26th 2017. As presented in other Danish societal analyses (Ministry of 
Finance, 2017) and in a Norwegian study (Hagen et al., 2012), the discount rate used in the 
analysis was set at 4%, making the investment in an LA-MRSA-free country comparable with 
other socioeconomic investments.  
 
 
Results 
The results of the cost analysis for the LA-MRSA eradication program are given in Table 2. 
The costs are divided into planning phase costs, direct net eradication costs during the five-year 
eradication phase, and derived net costs following eradication, as shown in Fig. 1. The 
percentage share of the total cost is also presented for each component. 
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TABLE 2. TOTAL ESTIMATED COST IN MILLIONS OF EUROS (M€) OF ERADICATING LA-MRSA IN DENMARK, DIVIDED 
INTO PLANNING COSTS AND COSTS DURING AND AFTER THE ERADICATION PERIOD 
 
 Costs Share 
(%) 
Phase: 
Planning Eradication Post 
eradication 
Total 
  
 
 M€ M€ M€ M€  
 Planning1 22 23 17 62 3 
- It was planned that LA-MRSA would be 
eradicated from 3,570 farms (some 
with multiple herds) during the 
eradication period, and a further 1,700 
farms post eradication, with an 
estimated cost of €13,440 per farm 
     
 Monitoring and testing1 8 56 45 109 6 
- During the planning phase, all 8,500 
herds were tested at a unit cost of 
€934. During the eradication phase, 
75,800 herds were expected to be 
tested at a cost of €934 per herd. Post 
eradication, all herds were expected to 
be tested once a year, which equates 
to 76,400 herds at the same cost in 
real prices. 
     
- Administration of the tests was 
expected to incur a cost of €0.3 M 
during the planning phase, €1.7 M in 
the eradication period and €1.8 M in 
the post-eradication phase 
     
- Administration of the tests was 
expected to incur a cost of €0.3 M 
during the planning phase, €1.7 M in 
the eradication period and €1.8 M in 
the post-eradication phase 
     
 Production gains and losses1   565 29 594 32 
- See Appendix 1      
 Cleaning and disinfection1    266 87 353 19 
- Cleaning and disinfection of 1.03      
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million sow pens (including weaner 
pens) was expected at a cost of €159 
per sow pen 
- It was expected that 4.5 million finisher 
pens would be cleaned in the 
eradication period and 223,000 pens in 
the post-eradication period, at a cost 
of €30.6 each 
     
 Net loss from breeding exports1   333 21 354 19 
- Number of breeding boars and gilts for 
export during the eradication phase 
was expected to decrease by 1.46 
million and by 119,000 for the post-
eradication period. The weighted price 
of the pigs in fixed prices was €316 per 
pig in real prices. The alternative price 
at slaughter was €121 
     
 
- Reduced income from semen, 
contracts and levy1 was estimated at 
€97 M in the eradication period and 
€2.5 M post eradication  
- See also Appendix 3 
     
 Loss of genetic progress1   179 186 365 20 
- See Appendix 2      
 Total1  30 1,422 385 1,837  
1) Present value for the relevant period. 
 
The total cost associated with eradicating LA-MRSA from positive pig herds in Denmark was 
estimated at €1,837 M. This is equivalent to approximately €2,000 per initially LA-MRSA-
positive sow, including costs related to weaners and finishers.  
 
Sensitivity analysis 
A sensitivity analysis was performed on what we considered to be the most influential 
assumptions of the analysis. As we initially chose conservative assumptions, the sensitivity 
analysis included only those changes resulting in higher costs. The adjustments made included 
changing the timescale from 15 to 20 years (by adding a longer post-eradication phase); setting 
the discount rate to 2% rather than 4%; reducing the future export of breeding animals by 25% 
compared to regaining full market share, and a 10% rather than 5% annual recurrence of LA-
MRSA following eradication. The cumulative effects of the changed assumptions were also 
calculated (Fig. 2).  
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FIG. 2. SENSITIVITY ANALYSIS IN COST ANALYSIS OF ERADICATION IN A HIGH PROPORTION OF 
HERDS. THE FIGURE SHOWS THE RELATIVE COST INCREASE FOR SIX SCENARIOS COMPARED TO 
A BASELINE SCENARIO FOR RELEVANT COST COMPONENTS. A: IF TIME HORIZON CONSIDERED 
WAS 20 YEARS; B: IF DISCOUNT RATE WAS CHOSEN TO BE 2 PERCENT; C: IF BOTH TIME 
HORIZON AND DISCOUNT RATE WAS ALTERED SIMULTANEOUSLY; D: IF THE 
REINTRODUCTION RATE WAS ASSUMED TO BE 10 PERCENT AFTER YEAR 6; E: IF THE EX POST 
ERADICATION EXPORT OF BREEDING ANIMALS AND SEMEN DROPPED BY 25 %; F: SCENARIOS 
A THROUGH E SIMULTANEOUSLY.  
 
The total costs were sensitive to a combined change in timescale and discount rate, and to a 
permanent drop in the export revenue from breeding, as the total costs increased by 
approximately 20%. If all assumptions were simultaneously changed to the presumed most 
unfavourable scenarios, the consequence was an 83% increase in the total costs (Fig. 2). If the 
recurrence rate was only half of the baseline scenario, i.e. 5% in the eradication phase and 2.5 
percent in the post eradication phase, this would reduce the total costs by 11%. 
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Discussion 
This study estimated the direct costs associated with a 15-year LA-MRSA eradication 
program. We calculated the costs of an eradication program consisting of: a planning phase of 
one year, an eradication campaign of five years, and nine years testing and re-stocking of farms 
with 5% herd reintroduction of LA-MRSA. A conservative approach to prices and 
consequences was chosen for the assumptions used in the model, and the estimated cost is 
therefore likely to be too low. However, compared to the potential savings of €106 M in direct 
costs (the present value of 15 years of savings) due to LA-MRSA in the public health sector 
(Christensen, 2017), the findings of our study suggest that eradication of LA-MRSA by 
depopulation of positive farms is not a cost-effective approach under Danish conditions. This is 
contrary to the conclusions reached in Norway (Norwegian Veterinary Institute, 2016), where 
the ‘trace and destroy’ strategy has been deemed cost-effective. Furthermore, a Swedish study 
(Höjgård et al., 2015) investigated the cost effectiveness of screening all imported animals and 
culling the LA-MRSA-positive animals, also deeming this to be economically worthwhile. 
However, the difference seems to be due to a difference in the proportion of positive herds in 
the initial situation. The theoretical association between the proportion of positive herds and 
the cost of control/eradication is shown in Fig. 3. This highlights the difference between a 
scenario with a low proportion of positive herds, such as the Norwegian LA-MRSA situation, 
and a scenario with a high proportion of positive herds, such as the Danish LA-MRSA 
situation. The shape of the cost curve and the location of the reported estimates are somewhat 
subjective. 
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FIG. 3. TYPICAL PHASES OF THE THEORETICAL SPREAD OF BACTERIA WITH THE APPARENT 
PROPORTION OF LA-MRSA-POSITIVE HERDS IN EUROPEAN COUNTRIES WHERE PIG 
PRODUCTION IS INTENSIVE (MODIFIED AFTER BEAN, 2015). PREVALENCE ESTIMATES WERE 
OBTAINED FROM ALT ET AL. (2011); BROENS ET AL. (2011); CROMBÉ ET AL. (2012); REYNAGA 
ET AL. (2016); DANISH VETERINARY AND FOOD ADMINISTRATION (2017) 
 
Some additional costs associated with eradication could be anticipated but were not quantified. 
An example would be the losses related to veterinarians being restricted in their planning and 
practice in order to prevent infecting negative herds. In addition, the anticipated losses 
associated with restrictions on the trade and transport of pigs were not quantified. The 
sensitivity analysis was performed for the assumptions we believed to be most uncertain. The 
most crucial assumption considered was the reintroduction rate, which we assumed to be 
comparable to those seen for endemic pig diseases. However, we have no real evidence to 
support what the post-eradication reintroduction rate of LA-MRSA would be in Denmark. The 
derived societal costs should also be investigated further to estimate the total costs of 
eradication of LA-MRSA in the Danish pig population. 
 
It could be argued that a potentially higher price for pig meat free from LA-MRSA should be 
considered in the cost analysis. The assumption of no price premium for LA-MRSA-free pig 
meat, however, seems realistic in the current situation where all major pig-producing countries 
have cases of LA-MRSA, and it is widely assumed that infected meat does not pose a health 
hazard. However, this may change in the future. 
 
 
Conclusion 
The costs of eradicating LA-MRSA from the pig population are considerable when the 
proportion of positive herds is as high as in Denmark. Associated benefits from improved 
human and pig health, and reduced costs in the hospital sector are much lower than the cost of 
eradication, which is why this option does not appear to be cost-effective in the Danish 
context.  
 
The conservative approach pursued here included a lower threshold of the expected costs, and 
the sensitivity analysis, which included plausible assumptions, showed a potential increase of 
83% in the total cost – from €1.8 billion to €3.4 billion. In the baseline scenario, 60% of the 
costs were due to eradication and production losses emerging from the eradication program, 
while 40% were due to losses in export and genetic progress. For countries predominantly 
importing their genetic materials, the total cost might be reduced by excluding the latter 
components. 
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Appendix 1 
Production losses 
The annual numbers of produced pigs of different age groups (Table A1) were used to calculate 
the production loss. 
 
TABLE A1. NUMBER OF PIGLETS, WEANERS AND SLAUGHTERED FINISHER PIGS PRODUCED IN 
DENMARK DURING 2016, USED TO CALCULATE THE EXPECTED OUTPUT LOSS 
Type of pig Thousand pigs 
Piglets produced 33,100  
Weaners produced 31,400  
Finishers slaughtered 17,800  
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The loss of expected output was calculated separately for specialised and integrated herds 
(Table 1), because the value of production loss was dependent on the duration of ceased 
production during eradication. Losses would be higher for an integrated herd in which the 
finisher section was emptied and cleaned before restocking. Within 12 weeks of emptying the 
farm, it was expected that the cleaning, disinfection and handling of manure would be 
complete. The period of operational losses was also dependent on the herd structure (Table 
A2).  
 
TABLE A2. PRODUCTION LOSS (IN WEEKS) FOR DIFFERENT PRODUCTION HERD TYPES (WITH 
OFF-SITE GESTATING GILTS) DURING EACH STAGE OF THE ERADICATION PROGRAM 
Herd type / Eradication 
program stage 
Depopulation Empty Restocking Operational 
losses 
Integrated, piglets 20 20 6 26 
Integrated, weaners 8 18 8 26 
Integrated, finisher pigs 13 26 13 39 
Specialised, piglets 20 14 6 20 
Specialised, weaners 8 12 8 20 
Specialised, finisher pigs 13 12 13 25 
 
 
The eradication process was not expected to be 100% successful due to reintroductions or 
unsuccessful eradication in the multiplier herds, resulting in subsequent production losses. The 
multiplier herds have contracts with the breeding company to multiply genes via high quality 
gilts to the production herds. Each multiplier herd subject to reintroduction was expected to 
result in a prolonged production loss at two production herds due to a failure in supplying gilts. 
If eradication was planned so that the supply of gilts matched the demand, then it would be 
necessary for a multiplier herd subject to reintroduction to suspend gilt supply to their 
customers. 
 
The assumed price of pig meat during an eradication phase influenced the production loss, 
with higher losses associated with higher prices and vice versa. The assumed price was chosen 
to cover costs exactly, which included all resources such as owner remuneration and return on 
equity. This break-even price would be predicted under perfect competition conditions 
including identical farms, and free entry and exit. Gross margins adjusted according to the 
description in the Materials and Method section and the break-even pig price are presented in 
Table A3. 
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TABLE A3. ADJUSTED GROSS MARGINS, IN EUROS (€), FOR LABOUR AND ENERGY. ESTIMATES 
USED FOR THE COST ANALYSIS FOR DIFFERENT TYPES OF PIGS  
Adjusted1 gross margins 
Euros 
(€) 
Gross margin per piglet produced 14.66 
Gross margin per weaner pig 4.98 
Gross margin per finisher pig 16.68 
1 Gross margin including share of energy and labour costs. 
 
The duration of the production loss, total production of LA-MRSA-positive pigs during a year 
per herd type, loss per unit produced, and total operational losses are presented in Table A4. 
 
TABLE A4. OPERATIONAL LOSSES IN DIFFERENT HERD TYPES GIVEN THE DURATION OF 
ERADICATION, THE PRODUCTION, AND THE LOSS PER UNIT PRODUCED 
Herd type, section 
Loss 
(weeks) 
Production 
(million pigs) 
Operational loss  
(€ per unit) 
Total operational 
loss (€ M) 
Integrated, piglets 26 26.3 25.2 185 
Integrated, weaners 26 15.9 15.3 38 
Integrated, finisher pigs 39 6.4 6.0 76 
Specialised, piglets 20 7.9 14.7 45 
Specialised, weaners 20 16.8 5.0 32 
Specialised, finisher pigs 25 12.2 16.7 98 
Total nominal 
operational loss 
   473 
 
The estimated time span of the production losses was five years because the supply of LA-
MRSA-negative gilts was expected to be limited. This supply was expected to be higher 
towards the end of the eradication program because the multiplier herds were expected to be 
free from LA-MRSA. Depopulation of a high proportion of the farms could be considered an 
opportunity to improve the general health of the pig population by reducing the prevalence of 
(or even eradicating) certain diseases such as PRRS, Porcine Pleuropneumonia and Enzootic 
Pneumonia. PRRS has been associated with an annual loss of €17 M (recalculated for 2016 
prices; Kristensen & Christiansen, 2013), and it was assumed that Actinobacillus 
pleuropneumoniae and Enzootic Pneumonia together would incur losses for Danish pig 
producers of the same magnitude, although Nathues et al., (2017) estimated higher losses for 
these diseases. 
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Appendix 2 
Loss of breeding progress 
The genetic progress was calculated for one of the breeds, and we assumed that it was similar 
for the two other breeds. With 2,000 breeding sows, the demand for testable gilts was about 
4,600 gilts per year, with a baseline replacement rate of 70% per litter (approximately 150% per 
year). The demand for boars was 100 per year for each breed.  
 
It was assumed that each sow would produce ten female and ten male piglets per year, totalling 
a potential 20,000 gilts per year for each breed, and yielding a selection intensity of 23% 
(4,600/20,000). The boar selection was 0.5% (100/20,000). During the eradication program, 
the gilt selection was 0%, as all gilts were expected to be utilised, and the boar selection was 
3.57% (100 used boars/(20,000 boars produced*(1-0.86 (eradicated share of nucleus herds)))). 
In Oldenbroek and Waaij (2014), the baseline selection for boars with 0.5% selection yielded a 
selection intensity (𝑖) of 2.89, and the 23% gilt baseline selection gave an intensity (𝑖) of 1.32. 
The eradication selection for boars with 3.57% selection yielded an intensity (𝑖) of 2.20 (by 
linear interpolation). The average selection intensity for sows and boars before eradication was 
2.106. The average selection intensity during the eradication program was calculated at 1.10, 
(2.20 before + 0 after)/2.  
 
The change in breeding progress was found using the ratio of breeding progress prior to and 
during eradication (1,100/2,106), leading to 52% of the breeding progress being sustained and 
consequently 48% of the breeding progress being lost during the eradication period. This was 
worth €1.7 * 47.8% = €0.81 per year for each pig.  
 
It was expected to take approximately 1.64 years before the production of gilts would return to 
the pre-eradication level, resulting in a selection intensity and breeding progress similar to that 
of pre-eradication levels. This meant that the loss sustained due to suspended genetic progress 
during the eradication program was €0.81 * 1.64 year = €1.33 per pig. 
 
If a caesarean strategy was not pursued, the full loss of genetic progress could be calculated as 
the annual production of 31.4 million pigs with a loss of €1.33 per pig, or €42 M per year. The 
breeding progress was a yearly loss, with a present value calculated at €425 M for years six to 
15.  
 
The cost of caesarean sections as a means to reduce breeding progress loss was approximated 
for the procedure outlined below. Each week, a number of the best sows should be transported 
to a caesarean facility, and the piglets subsequently bottle fed at an LA-MRSA-negative 
nursery. This should happen at a pace that could supply the farm with a sufficient number of 
useful gilts at the age of 35 weeks. After 21 weeks of performing caesareans, the number would 
be lowered to match the need for replacement gilts. Subsequently, the sow replacement rate 
was expected to be higher than usual due to the poorer health of the nursery pigs as a result of 
bottle feeding.  
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The correlation between the embryo genetic ranking and the genetic ranking at testing age was 
assumed to be 0.5. High gilt mortality caused by poor health led to the additional loss of 
genetic value. The cost of caesarean sections was estimated at €9,400 per litter, resulting in the 
total cost of the program being approximately €79 M. Use of caesareans was expected to 
reduce the loss of genetic progress by €142 M. With the cost of the program at €79 M, the 
savings would be €62 M, yielding a total estimated loss of breeding progress of €365 M.  
 
Danish pig production was also expected to be based primarily on Danavl gilts due to the 
availability of only a limited set of LA-MRSA-negative foreign gilts. It was assumed that 
50,000 Norwegian gilts could be imported into Denmark annually.   
 
 
Appendix 3 
Loss of export revenue for gilts, boars and semen 
Exported breeding animals have higher revenue compared to slaughter pigs if there is a foreign 
demand for Danish gilts. There was an expected reduction in the competitiveness of the 
Danavl breeding company following the eradication program because competitors could retain 
full breeding progress compared to the reduced progress of Danavl during the eradication 
period. Nonetheless, exports of gilts, boars and semen were expected to recover to full value 
seven years after the eradication program was initiated. 
 
The expected share of export market lost during the eradication program was estimated based 
on the principle that gilts testing positive for LA-MRSA could be exported until all nucleus and 
multiplier herds had undergone eradication (Table A5). It was expected that export value 
would revert to the baseline level by 2025.  
 
TABLE A5. SHARE OF THE EXPORT MARKET FOR BREEDING ANIMALS AND SEMEN EXPECTED 
TO BE LOST DUE TO AN ERADICATION STRATEGY. AN EXPORT LOSS IS ALSO EXPECTED AFTER 
THE ERADICATION PHASE DUE TO COMPETITION. 
 
2019 
% lost 
2020 
% lost 
2021 
% lost 
2022 
% lost 
2023 
% lost 
2024 
% lost 
Purebred gilts 5 100 100 75 50 25 
Crossbred gilts 5 50 100 100 50 25 
Danish Landrace and Yorkshire 
boars 
5 50 40 25 10 0 
Duroc boars 5 50 40 25 10 0 
Duroc semen 5 50 40 25 10 0 
Foreign internal breed 0 0 0 0 0 0 
Share of breed-tax lost (export) 5 90 90 75 40 15 
 
When gilts and boars were not exported, the animals were expected to be slaughtered. 
